← All trials
NCT04494646
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 8, 2020
- Primary completion
- Jan 30, 2021
- Completion date
- Feb 28, 2021
- First posted
- Jul 31, 2020
- Last posted
- Nov 3, 2020
- Enrollment
- 440
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- New York UniversityLead sponsor
- Reata Pharmaceuticals, Inc.Collaborator
- New York UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.